Scholars Central

Conference abstract

G protein/KCa/VDC channel linkage as a therapeutic target for asthma and COPD

Authors: Hiroaki Kume

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Bronchodilators are widely used for treatment of asthma and COPD. Airway smooth muscle tone is regulated by both muscarinic and β2-adrenergic action. Large-conductance Ca2+-activated K+ (KCa) channels are activated by M2-adrenergic receptor agonists, via Gs, and suppressed by muscarinic receptor antagonists via Gi. This functional antagonism converges on the G protein/KCa channel linkages. Membrane potential regulated by KCa channel activity contributes to airway smooth muscle tension via Ca2+ influx passing through voltage-dependent Ca2+ (VDC) channels. The Gs/KCa/VDC channel linkage is a key process in not only physiological effects, but also dysfunction of M2-adrenergic receptors and airway remodeling. Moreover, this pathway is involved in the synergistic effects between M2-adrenergic receptor agonists and muscarinic receptor antagonists. Intrinsic efficacy is also an important characteristic for both maintenance and loss of M2-adrenergic action. Allosteric modulators of G protein-coupled receptors contribute not only to this synergistic effect between M2-adrenergic and muscarinic M2 receptors, but also to intrinsic efficacy. The effects of weak partial agonists are suppressed by lowering receptor number, disordering receptor function, and enhancing functional antagonism; in contrast, those of full or strong partial agonists are not suppressed. Excessive exposure to full agonists causes M2-adrenergic desensitization; in contrast, exposure to partial agonists does not cause desensitization. Intrinsic efficacy may provide the rationale for the clinical use of M2-adrenergic receptor agonists in asthma and COPD. In conclusion, the G protein/KCa linkage and intrinsic efficacy (allosteric effects) may be therapeutic targets for research and development of novel agents against both airway obstruction and airway remodeling.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Pharmacovigilance.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Pharmacovigilance
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Hiroaki Kume”